This funding opportunity supports operational research aimed at optimizing preventive chemotherapy programs for diseases such as lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminthiasis, and trachoma. It emphasizes sustainable integration of Female Genital Schistosomiasis into sexual, reproductive, and primary health systems, providing funding and technical assistance for individual studies.
Eligibility criteria are not specified for this funding opportunity.
